Bonnie Betts, NP
Women's Health · North Las Vegas, NVNPI 1083852206
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 90 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 15.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,548 and has fallen 64.4% since, to $551 in 2025. Among women's health clinicians in NV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 90 payments — averaging $45.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurocrine Biosciences, Inc.$639
- Otsuka America Pharmaceutical, Inc.$633
- Alkermes, Inc.$615
- Axsome Therapeutics, Inc.$432
- E.r. Squibb & Sons, L.L.C.$305
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$286
- plus $1K from 13 others
What the payments were for
- Food & beverage$4,079100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurocrine Biosciences, Inc. | 17 | $639 |
| Otsuka America Pharmaceutical, Inc. | 6 | $633 |
| Alkermes, Inc. | 22 | $615 |
| Axsome Therapeutics, Inc. | 10 | $432 |
| E.r. Squibb & Sons, L.L.C. | 4 | $305 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $286 |
| Johnson & Johnson | 5 | $266 |
| AbbVie | 2 | $255 |
| Teva Pharmaceuticals USA, Inc. | 4 | $168 |
| Idorsia Pharmaceuticals US Inc | 3 | $138 |
| Bioxcel Therapeutics, Inc. | 2 | $113 |
| Boston Scientific | 1 | $77 |
| Almatica Pharma LLC | 3 | $58 |
| Sunovion Pharmaceuticals Inc. | 1 | $23 |
| Amgen | 1 | $18 |
| Organon | 1 | $15 |
| Lundbeck LLC | 1 | $13 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $13 |
| Bardy Diagnostics, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$465
- REXULTI$370
- VRAYLAR$255
- INGREZZA$254
- CAPLYTA$253
- COBENFY$247
- QUVIVIQ$125
- ABILIFY MYCITE$125
- Auvelity$122
- UZEDY$122
- ABILIFY MAINTENA$122
- ABILIFY ASIMTUFII$122
- SPRAVATO$115
How this compares
$4,079 in reported general payments places this provider in the 95th percentile of 36 women's health providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 13 | $13,369 |
| MounjaroTirzepatide | 11 | $12,463 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 23 | $1,672 |
| Celecoxib | 20 | $1,240 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 24 | $905 |
| Ondansetron Hcl | 15 | $560 |
| Fluticasone Propionate | 11 | $267 |
| ClopidogrelClopidogrel Bisulfate | 14 | $249 |
| Levothyroxine Sodium | 28 | $224 |
| Famotidine | 21 | $208 |
| Trazodone Hcl | 11 | $205 |
| Cyclobenzaprine Hcl | 12 | $202 |
| Atorvastatin Calcium | 43 | $158 |
| Omeprazole | 23 | $147 |
| Temazepam | 12 | $133 |
Paid to pharmacies, not to this prescriber.
Other women's health in North Las Vegas
- Christina ClignettNorth Las Vegas$776
- Adrienne DavisNorth Las Vegas$700
- Ruheena MadhuraNorth Las Vegas$441
- Tamara BaumannReno$7K
- Mee HanHenderson$4K
- Sara GaardeNellis Afb$3K
- Celena WilliamsHenderson$2K
- Luellen GreenlickLas Vegas$2K
- Rosanna PiacentiniLas Vegas$2K
- Sheila TackLas Vegas$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.